SCHEMBL13679028

SCHEMBL13679028

CC(C)OC(=O)N1CCCC(N(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)[S+](C)[O-])c2ccccc21

nearest known ligand 0.45

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CETP P11597 20/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1383212 0.86 CETP (0.56) CETP
SCHEMBL3826422 0.84 CETP (0.43) CETP
SCHEMBL1383337 0.84 CETP (0.47) CETP
SCHEMBL1383614 0.79 CETP (0.60) CETP
SCHEMBL1386306 0.79 CETP (0.67) CETP
SCHEMBL3528790 0.78 TACR1 (0.43) CETP
SCHEMBL1385695 0.78 CETP (0.57) CETP
SCHEMBL3536901 0.78 CETP (0.51) CETP
SCHEMBL3530899 0.77 CETP (0.56) CETP
SCHEMBL3537834 0.77 CETP (0.52) CETP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2098512-A1 Compounds and methods for treating dyslipidemia Eli Lilly & Company (US) 2009-09-09 EP disclosed